Close

content

Selexis SA and OSE Immunotherapeutics Collaborate to Advance Development of Immunotherapies for Cancer and Autoimmune Diseases

Selexis SA, a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, and OSE Immunotherapeutics SA announced the...

Cytori Granted FDA Orphan Drug Designation for ECCS-50 in Scleroderma

Cytori Therapeutics, Inc. announced that the US FDA Office of Orphan Products Development (OOPD) has granted Cytori an orphan drug designation for cryopreserved or...

Xellia Pharmaceuticals Commences Packaging and Distribution Operations at Cleveland Site after Successful FDA Inspection

Xellia Pharmaceuticals a specialty pharmaceutical company focusing on providing important anti-infective treatments against serious and often life-threatening infections, has received notice from the US...

CPhI & P-MEC India gets bigger with an exclusive ‘India Pharma Week 2016’

UBM India, India's leading exhibition organizer, is all set to host CPhI & P-MEC India 2016, one of the world’s leading pharmaceutical networking event...

Biothera Pharmaceuticals Preclinical Data Further Validate Mechanism of its Phase 2 Cancer Immunotherapy, Imprime PGG

Biothera Pharmaceuticals Inc will present new preclinical data that further validate the ability of its Phase 2 cancer immunotherapy drug Imprime PGG to induce...

Sanofi Receives CHMP Recommendation for Approval of SuliquaTM in the EU

Sanofi announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for...

Department of Heavy Industry (DHI), Govt. of India, to launchIndustry 4.0 at WIN INDIA 2016 in Mumbai

Hannover Milano Fairs India Pvt Ltd, organizers of the world’s largest trade fair Hannover Messe announced the 10th edition of WIN INDIA 2016, India’s...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read